指南与共识泌尿生殖介入USCTMR

ACR-ABS-ASTRO前列腺癌经会阴永久性近距离放射治疗实践参数

ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer.
指南 / 共识 · Am J Clin Oncol · 2022-05-06

美国放射学会、美国近距离放射治疗学会与美国放射肿瘤学会联合制定经会阴永久性近距离放射治疗前列腺癌的实践参数,涵盖人员资质与职责、患者选择标准、补充治疗使用、植入操作流程、术后剂量学评估及安全质量控制最佳实践。遵守既定标准有助于确保永久性前列腺近距离放射治疗安全有效实施。

要点

  • 该实践参数覆盖经会阴永久性近距离放射治疗前列腺癌的全流程规范。
  • 明确放射肿瘤科相关人员资质与职责,包括放疗医师、医学物理师、剂量师、放射治疗师和护理人员。
  • 涵盖患者选择标准及外照射放疗、雄激素剥夺治疗等补充治疗的使用。

核心结论

  • 遵守既定标准有助于确保永久性前列腺近距离放射治疗以安全有效的方式实施。
  • 该实践参数为低剂量率近距离放射治疗前列腺癌的适当使用提供框架,可作为单一治疗或与外照射放疗联合治疗方案的一部分。

研究设计与样本

  • 由美国放射学会(ACR)、美国近距离放射治疗学会(ABS)与美国放射肿瘤学会(ASTRO)联合制定。
  • 按照ACR网站「ACR实践参数与技术标准制定流程」所述流程,由放射肿瘤学委员会实践参数-放射肿瘤学专业委员会与ABS和ASTRO合作制定。

诊断标准与关键数值

  • 实践参数界定所有相关放射肿瘤学人员的资质与职责,包括放疗医师、医学物理师、剂量师、放射治疗师和护理人员。
  • 讨论患者选择标准及外照射放疗和雄激素剥夺治疗等补充治疗的使用。
  • 呈现植入操作流程、术后剂量学评估以及安全与质量控制方面的最佳实践。

临床应用与阅片要点

  • 该实践参数可用于规范经会阴永久性前列腺近距离放射治疗中人员资质、患者选择、植入操作、术后剂量学评估及安全质量控制。
  • 参数明确低剂量率近距离放射治疗可作为单一治疗或与外照射放疗联合治疗方案的一部分使用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM/OBJECTIVES/BACKGROUND: The American College of Radiology (ACR), American Brachytherapy Society (ABS), and American Society for Radiation Oncology (ASTRO) have jointly developed the following practice parameter for transperineal permanent brachytherapy of prostate cancer. Transperineal permanent brachytherapy of prostate cancer is the interstitial implantation of low-dose rate radioactive seeds into the prostate gland for the purpose of treating localized prostate cancer.

METHODS: This practice parameter was developed according to the process described under the heading The Process for Developing ACR Practice Parameters and Technical Standards on the ACR website (https://www.acr.org/Clinical-Resources/Practice-Parameters-and-Technical-Standards) by the Committee on Practice Parameters-Radiation Oncology of the Commission on Radiation Oncology, in collaboration with ABS and ASTRO.

RESULTS: This practice parameter provides a framework for the appropriate use of low-dose rate brachytherapy in the treatment of prostate cancer either as monotherapy or as part of a treatment regimen combined with external-beam radiation therapy. The practice parameter defines the qualifications and responsibilities of all involved radiation oncology personnel, including the radiation oncologist, medical physicist, dosimetrist, radiation therapist, and nursing staff. Patient selection criteria and the utilization of supplemental therapies such as external-beam radiation therapy and androgen deprivation therapy are discussed. The logistics of the implant procedure, postimplant dosimetry assessment, and best practices with regard to safety and quality control are presented.

CONCLUSIONS: Adherence to established standards can help to ensure that permanent prostate brachytherapy is delivered in a safe and efficacious manner.

来源:Am J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Bittner, Cox, Davis, et al. ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer. Am J Clin Oncol. 2022. PMID: 35588224. doi:10.1097/COC.0000000000000915

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。